Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study
Abstract Background Polycystic ovarian syndrome (PCOS) is a highly variable syndrome and one of the most common female endocrine disorders. Although the association inositols-glucomannan may represent a good therapeutic strategy in the treatment of PCOS women with insulin resistance, the effect of i...
Main Authors: | Jacopo Troisi, Claudia Cinque, Luigi Giugliano, Steven Symes, Sean Richards, David Adair, Pierpaolo Cavallo, Laura Sarno, Giovanni Scala, Maria Caiazza, Maurizio Guida |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | Journal of Ovarian Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13048-019-0500-x |
Similar Items
-
Results of treatment with myo-Inositol and D-chiro inositol combination in ratio 5:1 in women with polycystic ovary syndrome
by: Tatiana A. Oboskalova, et al.
Published: (2020-12-01) -
A comparative study of combination of Myo-inositol and D-chiro-inositol versus Metformin in the management of polycystic ovary syndrome in obese women with infertility
by: Sujana Thalamati
Published: (2020-12-01) -
Efficiency of the D-chiro-inositol for the polycystic ovary syndrome
by: Т. Л. Архипкина, et al.
Published: (2019-04-01) -
PCOS and Inositols: Controversial Results and Necessary Clarifications. Basic Differences Between D-Chiro and Myo-Inositol
by: Giovanni Monastra, et al.
Published: (2021-04-01) -
Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women
by: Mario Montanino Oliva, et al.
Published: (2018-05-01)